Compagnie Lombard Odier SCmA’s SOPHiA GENETICS SOPH Stock Holding History
Bought
Maintained
Sold
Other funds holding SOPH
BPC
AWA
HCM
BPCE
RG
HWAM
SBCM
Compagnie Lombard Odier SCmA's SOPH Position: Q2 2026 in Review
Compagnie Lombard Odier SCmA held its SOPHiA GENETICS (SOPH) position steady in Q2 2026 at 1,055 shares worth $6.09K. The position accounts for ﹤0.01% of the portfolio, ranked #431.
Compagnie Lombard Odier SCmA first reported a position in SOPH in Q3 2021 and has held it in 18 quarters since. The position peaked at $140K in Q3 2021. 19 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.
- Compagnie Lombard Odier SCmA held 1,055 shares of SOPHiA GENETICS worth $6.09K as of Q2 2026.
- Compagnie Lombard Odier SCmA left its SOPHiA GENETICS share count unchanged in Q2 2026.
- SOPHiA GENETICS made up ﹤0.01% of Compagnie Lombard Odier SCmA's portfolio in Q2 2026, its #431 holding.
- Compagnie Lombard Odier SCmA first reported a position in SOPHiA GENETICS in Q3 2021 and has held it in 18 quarters since.
- Compagnie Lombard Odier SCmA's SOPHiA GENETICS position peaked at $140K in Q3 2021.
- 19 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.
Based on Compagnie Lombard Odier SCmA's 13F filing for Q2 2026, filed 29 Jul 2026.